ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
패혈증 진단 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 8.2%의 CAGR로 14억 7,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 신속한 진단에 대한 수요 증가, 의료 인프라에 대한 투자 증가, 맞춤형 의료에 대한 관심 증가, 항균제 내성 증가, 차세대 시퀀싱의 사용 증가에 기인할 것으로 예상됩니다. 예측 기간 동안 예상되는 주요 동향으로는 진단에 AI의 통합, 바이오마커의 기술 발전, 분자진단의 발전, 자동화 및 디지털 진단 플랫폼으로의 전환, 진단에 있어 인공지능의 지속적인 발전 등이 있습니다.
병원내 감염(HAI)의 증가는 패혈증 진단제 시장의 성장을 촉진할 것으로 예상되며, HAI는 환자가 의료기관에 입원 중 또는 입원 후 발생하는 감염으로, 일반적으로 입원 후 48시간 이상 경과한 후 발병하며, 입원 당시에는 발병하지 않았던 감염을 말합니다. 항생제 내성 문제가 커지고 있는 것이 주요 원인입니다. 의료현장에서의 항생제 남용과 오남용이 내성균의 발생을 초래하여 감염증의 치료를 어렵게 만들고 있습니다. 패혈증 진단은 병원내 감염을 조기에 발견하여 적시에 치료하고 합병증을 줄일 수 있는 병원체 및 바이오마커를 식별하는 데 중요한 역할을 하고 있습니다. 예를 들어, 2024년 11월 호주보건복지연구원(Australian Institute of Health and Welfare)은 2022-2023년 의료관련감염(HAC)이 공립병원 입원의 2%, 사립병원 입원의 0.8%에서 발생했으며, HAI가 가장 빈번한 합병증으로 나타났다고 보고했습니다. 가장 빈번한 합병증으로 보고하였습니다. 그 결과, 병원내 감염 발생률의 증가가 패혈증 진단제 시장을 크게 견인하고 있습니다.
패혈증 진단 시장의 주요 기업들은 기존의 혈액 배양에 의존하지 않고 패혈증을 신속하고 정확하게 검출할 수 있는 무배양 진단 시스템과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 무배양 진단 시스템은 중합효소 연쇄 반응(PCR), 차세대염기서열분석(NGS), 면역분석 등 첨단 기술을 활용하여 혈액, 타액, 조직 등 환자 샘플에서 직접 병원균을 확인합니다. 예를 들어, 2024년 4월 스페인에 본사를 둔 Deepull Diagnostics S.L.사가 패혈증 조기 발견을 위한 UllCORE 진단 시스템을 출시했습니다. 이 배양 필요 없는 멀티플렉스 PCR 플랫폼은 패혈증 및 기타 급성 감염성 질환에서 병원균을 신속하게 식별할 수 있습니다. 이 시스템은 8mL의 전혈에서 미생물 DNA를 추출하여 단 1시간 만에 50개의 보고 가능한 결과를 제공합니다. 이 시스템은 박테리아, 곰팡이, 항생제 내성 유전자를 포함한 패혈증을 유발하는 병원균의 95%를 검출하여 조기 진단을 개선하고 항생제 오남용을 줄이는 동시에 병원이 항균제 내성을 퇴치할 수 있도록 돕습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 패혈증 진단 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 패혈증 진단 시장 : 성장률 분석
세계의 패혈증 진단 시장 실적 : 규모와 성장, 2019-2024
세계의 패혈증 진단 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 패혈증 진단 전체 시장(TAM)
제6장 시장 세분화
세계의 패혈증 진단 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
기기
혈액 배양 배지
어세이 키트와 시약
소프트웨어
세계의 패혈증 진단 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
미생물학
분자진단
면역측정
유세포 분석
기타 기술
세계의 패혈증 진단 시장 병원체별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세균성 패혈증
진균성 패혈증
바이러스성 패혈증
기타 병원체
세계의 패혈증 진단 시장 : 방법별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
자동 진단
기존 진단
세계의 패혈증 진단 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원과 진료소
병리학 및 표준 검사실
조사기관
세계의 패혈증 진단 시장, 제품별 기기 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
자동 분석기
POC(Point of Care) 검사 장비
미세유체 기반 디바이스
중합효소 연쇄 반응(PCR) 장비
유세포 분석기
세계의 패혈증 진단 시장 혈액 배양 배지 제품별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
호기성 혈액 배양 배지
혐기성 혈액 배양 배지
결핵균 혈액 배양 배지
소아용 혈액 배양 배지
진균 혈액 배양 배지
세계의 패혈증 진단 시장, 제품별 어세이 키트 및 시약 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
효소 면역측정(ELISA) 키트
중합효소 연쇄 반응(PCR) 어세이 키트
면역측정 시약
분자진단 시약
바이오센서 기반 어세이 키트
세계의 패혈증 진단 시장 소프트웨어 하위 세분화, 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
데이터 관리 소프트웨어
검사 정보 시스템(Lis)
인공지능(AI) 기반 진단 툴
예측 분석 소프트웨어
클라우드 기반 진단 플랫폼
제7장 지역별·국가별 분석
세계의 패혈증 진단 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 패혈증 진단 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
패혈증 진단 시장 : 경쟁 구도
패혈증 진단 시장 : 기업 개요
Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Becton, Dickinson and Company
Koninklijke Philips N.V.
GE Healthcare
Wolters Kluwer N.V.
bioMerieux S.A.
Bruker Corporation
DiaSorin S.p.A.
Cepheid Inc.
Seegene Inc.
Luminex Corporation
T2 Biosystems Inc.
Cytovale Inc.
Accelerate Diagnostics Inc.
Immunexpress Inc.
Sepsis Alliance
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
패혈증 진단 시장 2029 : 새로운 기회를 제공하는 국가
패혈증 진단 시장 2029 : 새로운 기회를 제공하는 부문
패혈증 진단 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Sepsis diagnostics refers to a range of advanced technologies and tests designed to quickly detect the presence of sepsis, a critical condition that can lead to organ failure and death if not treated promptly. These diagnostic tools enable healthcare providers to assess the severity of sepsis and make timely, informed decisions to initiate appropriate treatments, ultimately improving patient survival rates.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main products in sepsis diagnostics include instruments, blood culture media, assay kits and reagents, and software. Instruments are medical devices used to rapidly analyze blood samples and detect pathogens, allowing for the early and accurate identification of sepsis and facilitating timely treatment. Sepsis diagnostics employ various technologies such as microbiology, molecular diagnostics, immunoassays, and flow cytometry to detect different types of pathogens, including bacterial, fungal, viral sepsis, and others. The diagnostic methods include both automated and conventional diagnostic approaches. These tools are used by various end-users, including hospitals and clinics, pathology and reference laboratories, and research institutes.
The sepsis diagnostics market research report is one of a series of new reports from The Business Research Company that provides sepsis diagnostics market statistics, including the sepsis diagnostics industry global market size, regional shares, competitors with the sepsis diagnostics market share, detailed sepsis diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the sepsis diagnostics industry. This sepsis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The sepsis diagnostics market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to the increasing incidence of sepsis, growing awareness about the importance of early diagnosis, rising healthcare expenditure, a growing prevalence of hospital-acquired infections, and the increasing adoption of point-of-care testing.
The sepsis diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth during the forecast period can be attributed to the rising demand for rapid diagnostics, increasing investments in healthcare infrastructure, a growing focus on personalized medicine, the increasing prevalence of antimicrobial resistance, and the rising use of next-generation sequencing. Key trends expected in the forecast period include the integration of AI in diagnostics, technological advancements in biomarkers, progress in molecular diagnostics, a shift toward automated and digital diagnostic platforms, and the continued advancement of artificial intelligence in diagnostics.
The rising incidence of hospital-acquired infections (HAIs) is expected to drive growth in the sepsis diagnostics market. HAIs are infections that develop during or after a patient's stay in a healthcare facility, typically 48 hours or more after admission, and were not present at the time of admission. The increase in HAIs is largely due to the growing issue of antibiotic resistance. Overuse and misuse of antibiotics in healthcare settings have led to the development of resistant bacteria, making infections more difficult to treat. Sepsis diagnostics play a critical role by enabling early detection of hospital-acquired infections, identifying pathogens and biomarkers that allow for timely treatment and reduced complications. For instance, in November 2024, the Australian Institute of Health and Welfare reported that in 2022-2023, healthcare-associated infections (HACs) occurred in 2% of public hospital admissions and 0.8% of private hospital admissions, with HAIs being the most frequent complication. As a result, the rising incidence of hospital-acquired infections is significantly driving the sepsis diagnostics market.
Key players in the sepsis diagnostics market are focusing on the development of innovative solutions, such as culture-free diagnostic systems, to enable rapid and accurate detection of sepsis without relying on traditional blood cultures. Culture-free diagnostics leverage advanced technologies, including polymerase chain reaction (PCR), next-generation sequencing (NGS), or immunoassays, to identify pathogens directly from patient samples such as blood, saliva, or tissue. For example, in April 2024, Deepull Diagnostics S.L., a Spain-based company, launched the UllCORE diagnostic system for early sepsis detection. This culture-free, multiplex PCR platform provides rapid pathogen identification in sepsis and other acute infections. The system extracts microbial DNA from 8 mL of whole blood, offering 50 reportable results in just one hour. It detects 95% of sepsis-causing pathogens, including bacteria, fungi, and antibiotic resistance genes, helping hospitals combat antimicrobial resistance while improving early diagnosis and reducing antibiotic misuse.
In October 2024, Trinity Biotech plc, an Ireland-based medical laboratory company, acquired a 12.5% stake in Novus Diagnostics Ltd. for $2.5 million. This acquisition aims to accelerate the development and commercialization of Novus Diagnostics' rapid point-of-care diagnostic solutions, particularly its 15-minute bloodstream infection test. This rapid test is expected to significantly enhance sepsis diagnosis and improve patient outcomes by enabling faster and more accurate testing for bloodstream infections. Novus Diagnostics is an Ireland-based medical technology company developing diagnostic solutions for sepsis and other bloodstream infections.
Major players in the sepsis diagnostics market are Siemens Healthcare GmbH, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Wolters Kluwer N.V., bioMerieux S.A., Bruker Corporation, DiaSorin S.p.A., Cepheid Inc., Seegene Inc., Luminex Corporation, T2 Biosystems Inc., Cytovale Inc., Accelerate Diagnostics Inc., Immunexpress Inc., Sepsis Alliance.
North America was the largest region in the sepsis diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sepsis diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the sepsis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sepsis diagnostics market consists of revenues earned by entities by providing services such as clinical consultation, rapid diagnostic testing solutions, point-of-care diagnostic solutions, biomarker testing, and molecular diagnostic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The sepsis diagnostics market also includes sales of sepsis diagnostic test kits, automated blood culture systems, molecular diagnostic equipment, sepsis biomarker assay kits, and rapid diagnostic devices for infection detection. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sepsis Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sepsis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sepsis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sepsis diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Instruments; Blood Culture Media; Assay Kits And Reagents; Software
2) By Technology: Microbiology; Molecular Diagnostics; Immunoassays; Flow Cytometry; Other Technologies
3) By Pathogen: Bacterial Sepsis; Fungal Sepsis; Viral Sepsis; Other Pathogens
4) By Method: Automated Diagnostics; Conventional Diagnostics
5) By End-Users: Hospitals And Clinics; Pathology And Reference Laboratories; Research Institutes
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sepsis Diagnostics Market Characteristics
3. Sepsis Diagnostics Market Trends And Strategies
4. Sepsis Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Sepsis Diagnostics Growth Analysis And Strategic Analysis Framework
5.1. Global Sepsis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Sepsis Diagnostics Market Growth Rate Analysis
5.4. Global Sepsis Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Sepsis Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Sepsis Diagnostics Total Addressable Market (TAM)
6. Sepsis Diagnostics Market Segmentation
6.1. Global Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Blood Culture Media
Assay Kits And Reagents
Software
6.2. Global Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Other Technologies
6.3. Global Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacterial Sepsis
Fungal Sepsis
Viral Sepsis
Other Pathogens
6.4. Global Sepsis Diagnostics Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automated Diagnostics
Conventional Diagnostics
6.5. Global Sepsis Diagnostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Pathology And Reference Laboratories
Research Institutes
6.6. Global Sepsis Diagnostics Market, Sub-Segmentation Of Instruments, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automated Analyzers
Point-Of-Care (Poc) Testing Devices
Microfluidic-Based Devices
Polymerase Chain Reaction (Pcr) Instruments
Flow Cytometers
6.7. Global Sepsis Diagnostics Market, Sub-Segmentation Of Blood Culture Media, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aerobic Blood Culture Media
Anaerobic Blood Culture Media
Mycobacteria Blood Culture Media
Pediatric Blood Culture Media
Fungal Blood Culture Media
6.8. Global Sepsis Diagnostics Market, Sub-Segmentation Of Assay Kits And Reagents, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay (Elisa) Kits
Polymerase Chain Reaction (Pcr) Assay Kits
Immunoassay Reagents
Molecular Diagnostic Reagents
Biosensor-Based Assay Kits
6.9. Global Sepsis Diagnostics Market, Sub-Segmentation Of Software, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
